Results 221 to 230 of about 91,755 (270)

Neoadjuvant Therapy for Non‐Small Cell Lung Cancer: Recent Advances and Future Directions

open access: yesCancer Medicine, Volume 15, Issue 11, November 2026.
ABSTRACT Neoadjuvant therapy has become an integral component of the multidisciplinary management of resectable non–small cell lung cancer (NSCLC). The introduction of immune checkpoint inhibitors (ICIs) has transformed the perioperative treatment landscape by improving pathological response rates, reducing the risk of recurrence, and offering the ...
Hao An   +15 more
wiley   +1 more source

Biomarkers of nivolumab benefit in resectable non-small cell lung cancer. [PDF]

open access: yesNature
Cascone T   +30 more
europepmc   +1 more source

Intratumoral CTLA‐4 Blockade: Decoupling Local Immune Remodeling From Systemic Toxicity

open access: yes
MedComm – Oncology, Volume 5, Issue 4, December 2026.
Luyan Chen   +4 more
wiley   +1 more source

Variation in guideline decision-making: a cross-sectional study of oncology compendium panels. [PDF]

open access: yesHealth Aff Sch
Strohbehn GW   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy